Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

NCT02529800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HIP1402
DRUG: HGP0412

Sponsor

Hanmi Pharmaceutical Company Limited